Mutations in the IGF-II pathway that confer resistance to lytic reovirus infection

BMC Cell Biology

Volumn 5, Issue , 2004, Pages

  Sheng, Jinsong ^a,b   Organ, Edward L ^a,b,c   Hao, Chuanming ^a,b   Wells, K Sam ^b   Ruley, H Earl ^c   Rubin, Donald H ^a,b,c  

^a Research Medicine   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REGULATOR PROTEIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 5; TRANSCRIPTION FACTOR; CCCTC-BINDING FACTOR; DNA BINDING PROTEIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR CTCF;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLYSIS; GENE DISRUPTION; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC CODE; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; RAT; REOVIRUS; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; VIRUS ASSEMBLY; VIRUS INFECTION; VIRUS PARTICLE; VIRUS RESISTANCE; ANIMAL; BIOSYNTHESIS; CELL LINE; GENE EXPRESSION REGULATION; GENE TARGETING; GENETICS; MAMMALIAN ORTHOREOVIRUS; METABOLISM; MOLECULAR GENETICS; MUTAGENESIS; MUTATION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIRION;

MAMMALIAN ORTHOREOVIRUS 1; REOVIRUS SP.;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CELL PROLIFERATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE TARGETING; INSULIN-LIKE GROWTH FACTOR II; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTATION; ORTHOREOVIRUS, MAMMALIAN; RATS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; VIRION;

EID: 10444265850     PISSN: 14712121     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2121-5-32     Document Type: Article

References (54)

1. Arbour N, Cote G, Lachance C, Tardieu M, Cashman NR, Talbot PJ: Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol 1999, 73(4):3338-3350.
2. Kennedy PG, Clements GB, Brown SM: Differential susceptibility of human neural cell types in culture to infection with herpes simplex virus. Brain 1983, 106(Pt 1):101-119.
3. Tozzi V, Britton S, Ehrnst A, Lenkei R, Strannegard O: Persistent productive HIV infection in EBV-transformed B lymphocytes. J Med Virol 1989, 27(1):19-24.
4. Montgomery LB, Kao CY, Verdin E, Cahill C, Maratos-Flier E: Infection of a polarized epithelial cell line with wild-type reovirus leads to virus persistence and altered cellular function. J Gen Virol 1991, 72(Pt 12):2939-2946.
5. Morgan DO, Edman JC, Standring DN, Fried VA, Smith MC, Roth RA, Rutter WJ: Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 1987, 329(6137):301-307.
6. Tong PY, Tollefsen SE, Kornfeld S: The cation-independent mannose 6-phosphate receptor binds insulin-like growth factor II. J Biol Chem 1988, 263(6):2585-2588.
7. Bakay M, Zhao P, Chen J, Hoffman EP: A web-accessible complete transcriptome of normal human and DMD muscle. Neuromuscul Disord 2002, 12(Suppl 1):S125-141
8. Lobanenkov VV, Nicolas RH, Adler VV, Paterson H, Klenova EM, Polotskaja AV, Goodwin GH: A novel sequence-specific DMA binding protein which interacts with three regularly spaced direct repeats of the CCCTC-motif in the 5′-flanking sequence of the chicken c-myc gene. Oncogene 1990, 5(12):1743-1753.
9. Ahmed R, Graham AF: Persistent infections in L cells with temperature-sensitive mutants of reovirus. J Virol 1977, 23(2):250-262.
10. Ahmed R, Canning WM, Kauffman RS, Sharpe AH, Hallum JV, Fields BN: Role of the host cell in persistent viral infection: coevolution of L cells and reovoirus during persistent infection. Cell 1981, 25(2):325-332.
11. Blay J, Brown KD: Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells. J Cell Physiol 1985, 124(1):107-112.
12. Blay J, Brown KD: Functional receptors for epidermal growth factor in an epithelial-cell line derived from the rat small intestine. Biochem J 1985, 225(1):85-94.
13. Organ EL, Nalbantyan CD, Nanney LB, Woodward SC, Sheng J, Dubois RN, Price J, Sutcliffe M, Coffey RJ, Rubin DH: Effects of transforming growth factor-alpha (TGF-alpha) in vitro and in vivo on reovirus replication. DNA Cell Biol 2004, 23(7 ):430-441.
14. Rubin DH, Kornstein MJ, Anderson AO: Reovirus serotype 1 intestinal infection: a novel replicative cycle with ileal disease. J Virol 1985, 53(2):391-398.
15. Rubin DH: Reovirus serotype 1 binds to the basolateral membrane of intestinal epithelial cells. Microb Pathog 1987, 3(3):215-219.
16. von Melchner H, Reddy S, Ruley HE: Isolation of cellular promoters by using a retrovirus promoter trap. Proc Natl Acad Sci USA 1990, 87(10):3733-3737.
17. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM: CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 2000, 405(6785): 86-489.
18. Bell AC, Felsenfeld G: Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 2000, 405(6785):482-485.
19. Dull TJ, Gray A, Hayflick JS, Ullrich A: Insulin-like growth factor II precursor gene organization in relation to insulin gene family. Nature 1984, 310(5980):777-781.
20. Buchanan CM, Phillips AR, Cooper GJ: Preptin derived from proinsulin-like growth factor II (proIGF-ll) is secreted from pancreatic islet beta-cells and enhances insulin secretion. Biochem J 2001, 360(Pt 2):431-439.
21. Geuze HJ, Slot JW, Strous GJ, Hasilik A, von Figura K: Possible pathways for lysosomal enzyme delivery. J Cell Biol 1985, 101(6):2253-2262.
22. Johnson KF, Kornfeld S: A His-Leu-Leu sequence near the carboxyl terminus of the cytoplasmic domain of the cationdependent mannose 6-phosphate receptor is necessary for the lysosomal enzyme sorting function. J Biol Chem 1992, 267(24 ):17110-17115.
23. Ludwig T, Griffiths G, Hoflack B: Distribution of newly synthesized lysosomal enzymes in the endocytic pathway of normal rat kidney cells. J Cell Biol 1991, 115(6):1561-1572.
24. De Ceuninck F, Poiraudeau S, Pagano M, Tsagris L, Blanchard O, Willeput J, Corvol M: Inhibition of chondrocyte cathepsin B and L activities by insulin-like growth factor-ll (IGF-ll) and its Ser29 variant in vitro: possible role of the mannose 6-phosphate/IGF-ll receptor. Mol Cell Endocrinol 1995, 113(2):205-213.
25. Georgi A, Mottola-Hartshorn C, Warner A, Fields B, Chen LB: Detection of individual fluorescently labeled reovirions in living cells. Proc Natl Acad Sci USA 1990, 87(17):6579-6583.
26. Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de La Chapelle A: Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci USA 2001, 98(2):591-596.
27. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP: Relaxation of imprinted genes in human cancer. Nature 1993, 362(6422):747-749.
28. Wright JF, Kurosky A, Wasi S: An endothelial cell-surface form of annexin II binds human cytomegalovirus. Biochem Biophys Res Commun 1994, 198(3): 983-989.
29. Zhao WQ, Chen GH, Chen H, Pascale A, Ravindranath L, Quon MJ, Alkon DL: Secretion of Annexin II via activation of insulin receptor and insulin-like growth factor receptor. J Biol Chem 2003, 278(6):4205-4215.
30. Zhu Z, Gershon MD, Ambron R, Gabel C, Gershon AA: Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin. Proc Natl Acad Sci USA 1995, 92(8):3546-3550.
31. Brunetti CR, Burke RL, Kornfeld S, Gregory W, Masiarz FR, Dingwell KS, Johnson DC: Herpes simplex virus glycoprotein D acquires mannose 6-phosphate residues and binds to mannose 6-phosphate receptors J Biol Chem 1994, 269(25):17067-17074.
32. Visser M, Sijmons C, Bras J, Arceci RJ, Godfried M, Valentijn LJ, Voute PA, Baas F: Allelotype of pediatric rhabdomyosarcoma. Oncogene 1997, 15(11):1309-1314.
33. Lynch CA, Tycko B, Bestor TH, Walsh CP: Reactivation of a silenced H19 gene in human rhabdomyosarcoma by demethylation of DNA but not by histone hyperacetylation. Mol Cancer 2002, 1(1 ): 2.
34. Rainier S, Dobry CJ, Feinberg AP: Loss of imprinting in hepatoblastoma. Cancer Res 1995, 55(9):1836-1838.
35. Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP: Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 2002, 62(22):6442-6446.
36. McCann AH, Miller N, O'Meara A, Pedersen I, Keogh K, Gorey T, Dervan PA: Biallelic expression of the IGF2 gene in human breast disease. Hum Mol Genet 1996, 5(8): 1123-1127.
37. De Souza AT, Yamada T, Mills JJ, Jirtle RL: Imprinted genes in liver carcinogenesis. Faseb J 1997, 11(1 ):60-67.
38. Yun K, Soejima H, Merrie AE, McCall JL, Reeve AE: Analysis of IGF2 gene imprinting in breast and colorectal cancer by allele specific-. J Pathol 1999, 187:518-522.
39. Song BC, Chung YH, Kim JA, Lee HC, Yoon HK, Sung KB, Yang SH, Yoo K, Lee YS, Suh DJ: Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: a prospective study. Cancer 2001, 91(12):2386-2393.
40. Kawamoto K, Onodera H, Kondo S, Kan S, Ikeuchi D, Maetani S, Imamura M: Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: correlation with tumor progression, proliferative activity and survival. Oncology 1998, 55(3):242-248.
41. Duguay SJ, Jin Y, Stein J, Duguay AN, Gardner P, Steiner DF: Posttranslational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis. J Biol Chem 1998, 273(29):18443-18451.
42. Hirasawa K, Nishikawa SG, Norman KL, Alain T, Kossakowska A, Lee PW: Oncolytic reovirus against ovarian and colon cancer. Cancer Res 2002, 62(6):1696-1701.
43. Norman KL, Coffey MC, Hirasawa K, Demetrick DJ, Nishikawa SG, DiFrancesco LM, Strong JE, Lee PW: Reovirus oncolysis of human breast cancer. Hum Gene Ther 2002, 13(5):641-652.
44. Zwiebel JA: Cancer gene and oncolytic virus therapy. Semin Oncol 2001, 28(4):336-343.
45. Norman KL, Lee PW: Reovirus as a novel oncolytic agent. J Clin Invest 2000, 105(8):1035-1038.
46. Koike K, Tsutsumi T, Fujie H, Shintani Y, Kyoji M: Molecular mechanism of viral hepatocarcinogenesis. Oncology 2002, 62(Suppl 1):29-37.
47. Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM: Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 1985, 119(3 : 61-366.
48. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266(5192): 865-1869.
49. Hirshaut Y, Cohen MH, Stevens DA: Epstein-Barr-virus antibodies in American and African Burkitt's lymphoma. Lancet 1973, 2(7821):114-116.
50. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez Gl, Blaser MJ: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991, 325(16 : 132-1136.
51. McNamara D, O'Morain C: Helicobacter pylori and gastric cancer. Ital J Gastroenterol Hepatol 1998, 30(Suppl 3): 294-298.
52. Hicks GG, Shi EG, Li XM, Li CH, Pawlak M, Ruley HE: Functional genomics in mice by tagged sequence mutagenesis. Nat Genet 1997, 16(4):338-344.
53. Fields BN, Greene Ml: Genetic and molecular mechanisms of viral pathogenesis: implications for prevention and treatment. Nature 1982, 300(5887):19-23.
54. Smith RE, Zweerink HJ, Joklik WK: Polypeptide components of virions, top component and cores of reovirus type 3. Virology 1969, 39(4):791-810.